医学
急性冠脉综合征
血压
经皮冠状动脉介入治疗
重症监护医学
心肌梗塞
人口
内科学
戒烟
心理干预
临床试验
环境卫生
精神科
病理
作者
Furio Colivicchi,Angelo Di Roma,Massimo Uguccioni,Emilio Scotti,Fabrizio Ammirati,Marcello Arcas,Aniello Avallone,O Bonaccorso,Giuseppe Germanò,Claudio Letizia,Dario Manfellotto,Giovanni Minardi,Christian Pristipino,Francesco d’Amore,Claudio Di Veroli,Aldo Fierro,Ruggero Pastorellio,Quinto Tozzi,Marco Tubaro,Massimo Santini
出处
期刊:PubMed
日期:2010-05-01
卷期号:11 (5 Suppl 4): 3S-29S
被引量:4
摘要
Secondary prevention after acute coronary syndromes should be aimed at reducing the risk of further adverse cardiovascular events, thereby improving quality of life, and lengthening survival. Despite compelling evidence from large randomized controlled trials, secondary prevention is not fully implemented in most cases after hospitalization for acute coronary syndrome. The Lazio Region (Italy) has about 5.3 million inhabitants (9% of the entire Italian population). Every year about 11 000 patients are admitted for acute coronary syndrome in hospitals of the Lazio Region. Most of these patients receive state-of-the art acute medical and interventional care during hospitalization. However, observational data suggest that after discharge acute coronary syndrome patients are neither properly followed nor receive all evidence-based treatments. This consensus document has been developed by 11 Scientific Societies of Cardiovascular and Internal Medicine in order develop a sustainable and effective clinical approach for secondary cardiovascular prevention after acute coronary syndrome in the local scenario of the Lazio Region. An evidence-based simplified decalogue for secondary cardiovascular prevention is proposed as the cornerstone of clinical intervention, taking into account regional laws and relative shortage of resources. The following appropriate interventions should be consistently applied: smoking cessation, blood pressure control (blood pressure < 130/80 mmHg), optimal lipid management (LDL cholesterol < 80 mmHg), weight and diabetes management, promotion of physical activity and rehabilitation, correct use of antiplatelet agents, beta-blockers, renin-angiotensin-aldosterone system blockers.
科研通智能强力驱动
Strongly Powered by AbleSci AI